Endoscopic bariatric therapies for obesity: a review
| Autor: | Adrian Sartoretto, Dominic A Staudenmann, Payal Saxena, Patrick Aepli, Arthur J. Kaffes, Vivek Kumbhari, Zhixian Sui, George Marinos |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
medicine.medical_specialty Gastroplasty Bariatric Surgery Overweight Patient acceptance law.invention Randomized controlled trial Weight loss law Lifestyle intervention Weight Loss medicine Humans Obesity Intensive care medicine Gastric Balloon Randomized Controlled Trials as Topic business.industry Australia Endoscopy General Medicine medicine.disease Treatment Outcome medicine.symptom business |
| Zdroj: | The Medical journal of Australia. 215(4) |
| ISSN: | 1326-5377 |
| Popis: | ▪ Obesity is reaching pandemic proportions globally, with overweight or obesity affecting at least two-thirds of Australian adults. ▪ Bariatric surgery is an effective weight loss strategy but is constrained by high resource requirements and low patient acceptance. ▪ Multiple endoscopic bariatric therapies have matured, with well established and favourable safety and efficacy profiles in multiple randomised controlled trials (RCTs), and are best used within a multidisciplinary setting as an adjuvant to lifestyle intervention. ▪ Three types of intragastric balloon are currently in use in Australia offering average total weight loss ranging from 10% to 18%, with others available internationally. ▪ Endoscopic sleeve gastroplasty produces average total weight loss of 15-20% with low rates of severe complications, with RCT data anticipated in December 2021. ▪Bariatric and metabolic endoscopy is rapidly evolving, with many novel, promising therapies currently under investigation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text